Skip to main content
. Author manuscript; available in PMC: 2021 Jun 4.
Published in final edited form as: Cancer Discov. 2020 Jan 8;10(3):394–405. doi: 10.1158/2159-8290.CD-19-1130

Table 2.

Grade ≥3 AEs observed in >2 patients

All patients (N = 45)
Grade 3/4 AE, n(%) Grade 3 Grade 4
Neutrophil count decreased   5 (11)   6 (13)

Syncope   5 (11)   0 (0)

Platelet count decreased   3 (7)   1 (2)

Weight increased   4 (9)   0 (0)

Cellulitis   4 (9)   0 (0)

Hypophosphatemia   3 (7)   0 (0)

Hypertension   3 (7)   0 (0)

Pneumonia   2 (4)   0 (0)

Anemia   2 (4)   0 (0)

Diarrhea   2 (4)   0 (0)

Fall   2 (4)   0 (0)

Dyspnea   2 (4)   0 (0)